Skip to main content
Figure 3 | Cardiovascular Diabetology

Figure 3

From: The dipeptidyl peptidase-4 inhibitor Saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients

Figure 3

Gene expression analysis of diabetic and healthy PACs. A) Gene expression was determined in the whole PACs population obtained from type 2 diabetic patients (T2D) and healthy subjects (Ctrl). Expression is reported relative to the housekeeping gene as 2ΔCT. Note the logarithmic scale. *p < 0.05 T2D versus Ctrl. B) Expression of a selected number of genes found to be differentially expressed in (A) was tested in CD14+ monocytic and in CD14- lymphocytic PACs separately. *p < 0.05 in CD14+ vs CD14- cells; †p < 0.05 versus the control condition.

Back to article page